Rising Prevalence Of Metabolic Disorders Fueling The Growth Of The Market Due To Increasing Demand For Metabolic Disease Management: Strategic Insights Driving Isovaleric Acidemia (IVA) Treatment Market Momentum in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Isovaleric Acidemia (IVA) Treatment Market Size By 2025?
The market for isovaleric acidemia (IVA) treatment has seen robust expansion in the past few years, with its value set to increase from $0.6 billion in 2024 to $0.63 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.5%. The driving factors for the growth during the past period include a heightened consciousness regarding rare metabolic disorders, an upsurge in newborn screening schemes, government monetary support towards orphan diseases, an augmented focus on enzyme replacement therapies, coupled with a swelling demand for early detection and genetic advice.

How Big Is the Isovaleric Acidemia (IVA) Treatment Market Size Expected to Grow by 2029?
Expectations for the isovaleric acidemia (IVA) treatment market are optimistic, with significant expansion anticipated in the ensuing years. The market is projected to reach a worth of $0.79 billion by 2029, with a compound annual growth rate (CAGR) of 5.8%. This projected growth during the forecasted period can be linked to the escalating acceptance of gene therapy strategies, swelling investments in rare disease research, an expanding catalog of innovative treatment solutions, increased cooperation between biotech companies and research institutions, and a heightened emphasis on personalized medicine for metabolic disorders. Key trends for the forecasted period encompass progress in genetic testing technologies, sophisticated drug delivery systems for metabolic treatments, inventive enzyme replacement formulations, production of designed gene editing tools, along with improvements in newborn screening procedural techniques.

View the full report here:
https://www.thebusinessresearchcompany.com/report/isovaleric-acidemia-iva-treatment-global-market-report

Which Key Market Drivers Powering Isovaleric Acidemia (IVA) Treatment Market Expansion and Growth?
The rise in metabolic disorder incidences is projected to stimulate the isovaleric acidemia (IVA) treatment market's expansion. Metabolic disorders impair the regular metabolic functions, impacting the body's ability to transform food into energy. Diabetes mellitus, hypothyroidism, hyperthyroidism, ket*onuria (PKU), galactosemia, maple syrup urine disease (MSUD), isovaleric acidemia (IVA), Gaucher's disease, Fabry's disease, Wilson's disease, and various lysosomal storage disorders are among the most common metabolic disorders. The increase in metabolic disorders can be attributed to lifestyle factors such as unhealthy diets and physical inactivity, leading to conditions like obesity and insulin resistance. The treatment of isovaleric acidemia assists in controlling metabolic disorders by tackling the accumulation of harmful compounds in the body, reestablishing typical metabolic operation, and averting issues like neurological damage. For example, according to the American Diabetes Association, a non-profit organization based in the US, about 25.5 million US residents were diagnosed with diabetes in 2022, making up 7.6% of the entire population. Consequently, the escalating occurrence of metabolic disorders fuels the growth of the isovaleric acidemia (IVA) treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24269&type=smp

What Are the Emerging Segments in the Isovaleric Acidemia (IVA) Treatment Market?
The isovaleric acidemia (iva) treatment market covered in this report is segmented -

1) By Type: Classical Isovaleric Acidemia, Moderate Isovaleric Acidemia, Non-classical Isovaleric Acidemia
2) By Treatment: Dietary Management, Enzyme Replacement Therapy, Gene Therapy, Pharmacological Treatment
3) By Route of Administration: Oral, Injectable
4)By End-user: Hospitals, Clinics, Homecare Settings

Subsegments:
1) By Classical Isovaleric Acidemia: Dietary Management, Carnitine Supplementation, Glycine Supplementation, Emergency Management, Gene Therapy (Investigational)
2) By Non-classical Isovaleric Acidemia: Observation and Preventive Care, Mild Dietary Modifications, Occasional Supplementation, Genetic Counseling and Monitoring
3) By Moderate Isovaleric Acidemia: Protein-restricted Diet, Intermittent Carnitine/Glycine Therapy, Periodic Monitoring and Supportive Care, Acute Episode Management

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24269&type=smp

Who Are the Global Leaders in the Isovaleric Acidemia (IVA) Treatment Market?
Major companies operating in the isovaleric acidemia (IVA) treatment market are Nestlé Health Science S.A., BioMarin Pharmaceutical Inc., GenScript Biotech Corporation, Nutricia Advanced Medical Nutrition, Rocket Pharmaceuticals Inc., REGENXBIO Inc., uniQure N.V., Vitaflo International Ltd., Orchard Therapeutics plc, Editas Medicine Inc., Cambrooke Therapeutics Inc., Recordati Rare Diseases Inc., Abbott Nutrition, Targeted Medical Pharma Inc., Solace Nutrition LLC, Nutricia Metabolics, Bluebird Bio Inc., Verve Therapeutics Inc., Abeona Therapeutics Inc., CRISPR Therapeutics AG

Which are the Top Profitable Regional Markets for the Isovaleric Acidemia (IVA) Treatment Industry?
North America was the largest region in the isovaleric acidemia (IVA) treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the isovaleric acidemia (IVA) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24269

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.